Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAHD2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C4BPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSBP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CPLX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505585 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTAG1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBE2J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCOC-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCXD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGGHG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUSC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NME6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR8B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC23A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on